Cargando…
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
BACKGROUND: The current study aimed to evaluate growth and neurodevelopmental status in patients with retinopathy of prematurity (ROP) treated with intravitreal bevacizumab (IVB). METHODS: This historical cohort study was conducted on neonates with ROP who were treated with IVB and age and birth wei...
Autores principales: | Abrishami, Majid, Boskabadi, Hassan, Abrishami, Mojtaba, Shekarchian, Farid, Khadem-Rezaiyan, Majid, Shoeibi, Nasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594208/ https://www.ncbi.nlm.nih.gov/pubmed/34784985 http://dx.doi.org/10.1186/s40942-021-00340-6 |
Ejemplares similares
-
Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
por: Shoeibi, Nasser, et al.
Publicado: (2018) -
Incidence and Risk Factors of Retinopathy of Prematurity in Mashhad, Northeast Iran
por: Abrishami, Majid, et al.
Publicado: (2013) -
Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
por: Chang, Yu-Shan, et al.
Publicado: (2019) -
Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
por: Pawar, Neelam, et al.
Publicado: (2023) -
Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity
por: Arima, Mitsuru, et al.
Publicado: (2020)